Lexaria Bioscience Corp

Lexaria Bio Science signs 5-year deal to provide technology to Universal Hemp

Lexaria Bioscience Corp (CSE:LXX) Chairman and CEO Chris Bunka joined Steve Darling from Proactive Investors Vancouver on Skype to bring news the company has agreed to a 5-year deal that will allow Universal Hemp to use their DehydraTECH technology.

This deal will work under a royalty agreement but terms of that part of the deal are not being disclosed, but the deal is worth a min 3.75 million US.


Quick facts: Lexaria Bioscience Corp

Price: $0.89

Market: CSE
Market Cap: $69.99 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Lexaria Bioscience Corp named herein, including the promotion by the Company of Lexaria Bioscience Corp in any Content on the Site, the Company...



Full interview: Lexaria Bioscience ChrgD up about CBD product launch in the U.S.

Lexaria BioScience (CSE: LXX-OTCQX-LXRP) CEO Chris Bunka joined Steve Darling from Proactive Canada to discuss the company launching a new product featuring hemp oil in a powdered format.  Bunka talks about ChrgD and why this product can demonstrate Lexaria's ability to deliver CBD into...

on 08/22/2019

2 min read